250 related articles for article (PubMed ID: 8001887)
1. [Antibody-conjugated cytostatic drugs. Uses of monoclonal antibodies for new strategies in tumor therapy].
Renner C; Pfreundschuh M
Fortschr Med; 1994 Oct; 112(29):399. PubMed ID: 8001887
[No Abstract] [Full Text] [Related]
2. Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies.
Manzke O; Russello O; Leenen C; Diehl V; Bohlen H; Berthold F
Med Pediatr Oncol; 2001 Jan; 36(1):185-9. PubMed ID: 11464879
[TBL] [Abstract][Full Text] [Related]
3. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
4. [Bispecific antibodies in hematology and oncology].
Repp R; Valerius T; Bargou R
Internist (Berl); 2001 Jun; 42(6):854-9. PubMed ID: 11449632
[No Abstract] [Full Text] [Related]
5. A revival of bispecific antibodies.
Kufer P; Lutterbüse R; Baeuerle PA
Trends Biotechnol; 2004 May; 22(5):238-44. PubMed ID: 15109810
[No Abstract] [Full Text] [Related]
6. Cytokine targeting in tumors using a bispecific antibody directed against carcinoembryonic antigen and tumor necrosis factor alpha.
Robert B; Mach JP; Mani JC; Ychou M; Folli S; Artus JC; Pèlegrin A
Cancer Res; 1996 Oct; 56(20):4758-65. PubMed ID: 8840995
[TBL] [Abstract][Full Text] [Related]
7. Biotechnology-2009 AAPS national conference. 21-24 June 2009, Seattle, WA, USA.
Wu C
IDrugs; 2009 Sep; 12(9):539-42. PubMed ID: 19697269
[No Abstract] [Full Text] [Related]
8. Monoclonal antibody therapy of cancer.
Jurcic JG; Scheinberg DA; Houghton AN
Cancer Chemother Biol Response Modif; 1997; 17():195-216. PubMed ID: 9551215
[No Abstract] [Full Text] [Related]
9. [Dual-specificity therapeutic antibodies].
Winckler T
Pharm Unserer Zeit; 2009; 38(5):395-6. PubMed ID: 19711313
[No Abstract] [Full Text] [Related]
10. Smarter drugs: a focus on pan-specific monoclonal antibodies.
Fagète S; Fischer N
BioDrugs; 2011 Dec; 25(6):357-64. PubMed ID: 22050338
[TBL] [Abstract][Full Text] [Related]
11. Bispecific monoclonal antibodies for the targeting of type I ribosome-inactivating proteins against hematological malignancies.
Ferrini S; Sforzini S; Canevari S
Methods Mol Biol; 2001; 166():177-92. PubMed ID: 11217367
[No Abstract] [Full Text] [Related]
12. Monoclonal antibodies: does sufficient selectivity to cancer cells exist for therapeutic application?
Oldham RK
J Biol Response Mod; 1987 Jun; 6(3):227-34. PubMed ID: 3298552
[No Abstract] [Full Text] [Related]
13. Bispecific antibodies for cancer therapy.
Chames P; Baty D
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):276-83. PubMed ID: 19333873
[TBL] [Abstract][Full Text] [Related]
14. Americas Antibody Congress 2009. 21-23 September 2009, Washington DC, USA.
Reyes CL
IDrugs; 2009 Nov; 12(11):692-4. PubMed ID: 19844854
[TBL] [Abstract][Full Text] [Related]
15. Immunology. Two-in-one designer antibodies.
Parren PW; Burton DR
Science; 2009 Mar; 323(5921):1567-8. PubMed ID: 19299606
[No Abstract] [Full Text] [Related]
16. Recombinant bispecific antibodies for cellular cancer immunotherapy.
Müller D; Kontermann RE
Curr Opin Mol Ther; 2007 Aug; 9(4):319-26. PubMed ID: 17694444
[TBL] [Abstract][Full Text] [Related]
17. MT110: a novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors.
Brischwein K; Schlereth B; Guller B; Steiger C; Wolf A; Lutterbuese R; Offner S; Locher M; Urbig T; Raum T; Kleindienst P; Wimberger P; Kimmig R; Fichtner I; Kufer P; Hofmeister R; da Silva AJ; Baeuerle PA
Mol Immunol; 2006 Mar; 43(8):1129-43. PubMed ID: 16139892
[TBL] [Abstract][Full Text] [Related]
18. Intervention in receptor tyrosine kinase-mediated pathways: recombinant antibody fusion proteins targeted to ErbB2.
Wels W; Groner B; Hynes NE
Curr Top Microbiol Immunol; 1996; 213 ( Pt 3)():113-28. PubMed ID: 8815001
[No Abstract] [Full Text] [Related]
19. Monoclonal antibodies in adult acute lymphoblastic leukemia.
Kantarjian H
Hematology; 2012 Apr; 17 Suppl 1():S52-4. PubMed ID: 22507779
[TBL] [Abstract][Full Text] [Related]
20. Antibodies and gene therapy: teaching old 'magic bullets' new tricks.
Sanz L; Blanco B; Alvarez-Vallina L
Trends Immunol; 2004 Feb; 25(2):85-91. PubMed ID: 15102367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
